Ang, Y. S., Bruder, G. E., Keilp, J. G., Rutherford, A., Alschuler, D. M., Pechtel, P., Webb, C. A., Carmody, T., Fava, M., Cusin, C., McGrath, P. J., Weissman, M., Parsey, R., Oquendo, M. A., McInnis, M. G., Cooper, C. M., Deldin, P., Trivedi, M. H., & Pizzagalli, D. A. (2022). Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial. Psychological Medicine, 52(13), 2441-2449. https://doi.org/10.1017/S0033291720004286
Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial. / Ang, Yuen Siang; Bruder, Gerard E.; Keilp, John G. et al.
In:
Psychological Medicine, Vol. 52, No. 13, 20.10.2022, p. 2441-2449.
Research output: Contribution to journal › Article › peer-review
Ang, YS, Bruder, GE, Keilp, JG, Rutherford, A, Alschuler, DM, Pechtel, P, Webb, CA, Carmody, T, Fava, M, Cusin, C, McGrath, PJ, Weissman, M, Parsey, R, Oquendo, MA, McInnis, MG, Cooper, CM, Deldin, P, Trivedi, MH & Pizzagalli, DA 2022, 'Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial', Psychological Medicine, vol. 52, no. 13, pp. 2441-2449. https://doi.org/10.1017/S0033291720004286
Ang YS, Bruder GE, Keilp JG, Rutherford A, Alschuler DM, Pechtel P et al. Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial. Psychological Medicine. 2022 Oct 20;52(13):2441-2449. doi: 10.1017/S0033291720004286
Ang, Yuen Siang ; Bruder, Gerard E. ; Keilp, John G. et al. / Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial. In: Psychological Medicine. 2022 ; Vol. 52, No. 13. pp. 2441-2449.
@article{b29202c7215a4da889ca1040ace5bd60,
title = "Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial",
keywords = "Biomarkers, bupropion, cognitive control, depression, placebo response, reward learning, sertraline, treatment response",
author = "Ang, {Yuen Siang} and Bruder, {Gerard E.} and Keilp, {John G.} and Ashleigh Rutherford and Alschuler, {Daniel M.} and Pia Pechtel and Webb, {Christian A.} and Thomas Carmody and Maurizio Fava and Cristina Cusin and McGrath, {Patrick J.} and Myrna Weissman and Ramin Parsey and Oquendo, {Maria A.} and McInnis, {Melvin G.} and Cooper, {Crystal M.} and Patricia Deldin and Trivedi, {Madhukar H.} and Pizzagalli, {Diego A.}",
note = "Publisher Copyright: {\textcopyright} The Author(s), 2020. Published by Cambridge University Press.",
year = "2022",
month = oct,
day = "20",
doi = "10.1017/S0033291720004286",
language = "English",
volume = "52",
pages = "2441--2449",
journal = "Psychological Medicine",
issn = "0033-2917",
publisher = "Cambridge University Press",
number = "13",
}
TY - JOUR
T1 - Exploration of baseline and early changes in neurocognitive characteristics as predictors of treatment response to bupropion, sertraline, and placebo in the EMBARC clinical trial
AU - Ang, Yuen Siang
AU - Bruder, Gerard E.
AU - Keilp, John G.
AU - Rutherford, Ashleigh
AU - Alschuler, Daniel M.
AU - Pechtel, Pia
AU - Webb, Christian A.
AU - Carmody, Thomas
AU - Fava, Maurizio
AU - Cusin, Cristina
AU - McGrath, Patrick J.
AU - Weissman, Myrna
AU - Parsey, Ramin
AU - Oquendo, Maria A.
AU - McInnis, Melvin G.
AU - Cooper, Crystal M.
AU - Deldin, Patricia
AU - Trivedi, Madhukar H.
AU - Pizzagalli, Diego A.
N1 - Publisher Copyright:
© The Author(s), 2020. Published by Cambridge University Press.
PY - 2022/10/20
Y1 - 2022/10/20
KW - Biomarkers
KW - bupropion
KW - cognitive control
KW - depression
KW - placebo response
KW - reward learning
KW - sertraline
KW - treatment response
UR - http://www.scopus.com/inward/record.url?scp=85096686358&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85096686358&partnerID=8YFLogxK
U2 - 10.1017/S0033291720004286
DO - 10.1017/S0033291720004286
M3 - Article
AN - SCOPUS:85096686358
SN - 0033-2917
VL - 52
SP - 2441
EP - 2449
JO - Psychological Medicine
JF - Psychological Medicine
IS - 13
ER -
